BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with It's About to Be Hot Peptide Summer GQ From Looksmaxxing to FDA Approval? The U.S. Considers Greenlighting Mystery Peptides Peptide Therapy for Inflammation: A New Solution BPC 157: What Research Shows (and What It Doesn't) Meeting Point Health